Corcept Therapeutics Incorporated
CORT
$69.57
$0.751.09%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 35.15M | 20.55M | 30.75M | 47.21M | 35.49M |
| Total Depreciation and Amortization | 469.00K | 462.00K | 460.00K | 499.00K | 198.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -53.00K | 6.43M | 10.75M | -1.97M | -1.78M |
| Change in Net Operating Assets | 8.37M | -22.31M | 17.35M | 28.09M | 7.28M |
| Cash from Operations | 43.94M | 5.13M | 59.30M | 73.83M | 41.19M |
| Capital Expenditure | -57.00K | -104.00K | -121.00K | -1.64M | -416.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 70.18M | -3.07M | -64.24M | -42.40M | -59.78M |
| Cash from Investing | 70.13M | -3.17M | -64.36M | -44.04M | -60.19M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 12.51M | 3.46M | 2.42M | 2.27M | 3.24M |
| Repurchase of Common Stock | -115.44M | -43.26M | -6.99M | -23.36M | -5.39M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -102.93M | -39.80M | -4.56M | -21.09M | -2.15M |
| Foreign Exchange rate Adjustments | 1.79M | -- | -- | -- | -6.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 12.93M | -37.85M | -9.62M | 8.70M | -21.16M |